886499-99-6

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
3-Fluoro-5-(trifluoromethyl)benzenesulphonyl chloride is used as a reagent in organic synthesis for the production of pharmaceuticals and agrochemicals. Its strong electrophilic nature allows it to be a key component in the creation of bioactive molecules, contributing to the development of new drugs and pesticides.
Used in Dye, Pigment, and Polymer Manufacturing:
3-Fluoro-5-(trifluoromethyl)benzenesulphonyl chloride is also utilized in the manufacturing of dyes, pigments, and polymers due to its versatile reactivity. Its unique chemical structure and properties enable the production of a wide range of colorants and materials with specific characteristics.
Safety Considerations:

Upstream product

• 454-67-1 3-fluoro-5-trifluoromethylaniline 

Downstream Products

• 1208101-69-2 [(R)-5-(3-fluoro-5-trifluoromethyl-benzenesulfonylamino)-5,6,7,8-tetrahydro-naphthalen-1-yloxy]-acetic acid tert-butyl ester 
• 1349632-99-0 9-{[3-fluoro-5-(trifluoromethyl)phenyl]sulfonyl}-2,9-diazaspiro[5.5]undecan-1-one 
• 1349632-94-5 8-{[3-fluoro-5-(trifluoromethyl)phenyl]sulfonyl}-2,8-diazaspiro[4.5]decan-1-one 
• 1349643-76-0 7-{[3-fluoro-5-(trifluoromethyl)phenyl]sulfonyl}-2,7-diazaspiro[4.5]decan-1-one 
• 1349643-79-3 8-{[3-fluoro-5-(trifluoromethyl)phenyl]sulfonyl}-2,8-diazaspiro[5.5]undecan-1-one 

Relevant academic research and scientific papers

SUBSTITUTED AMINOTETRALINES

The invention is concerned with the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein R1-R4 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds of formula I are antagonists at the CRTH2 receptor and may be useful in treating diseases and disorders associated with that receptor such as asthma

MONOARYL AMINOTETRALINES

The invention is concerned with the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein R1, R2 and R3 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds of formula I are antagonists at the CRTH2 receptor and may be useful in treating diseases and disorders associated with that receptor such as asthma.

AMINOTETRAHYDROINDAZOLOACETIC ACIDS

The invention is concerned with the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein Q, R1-R3 and n are defined in the detailed description and claims. In addition, the present invention relates to methods of manuf

AMINOTETRAHYDROINDAZOLOACETIC ACIDS

The invention is concerned with the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein Q, W, X, R1-R5 and n are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds of formula I are antagonists at the CRTH2 receptor and may be useful in treating diseases and disorders associated with that receptor such as asthma.